Publication

Byline

Location

Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... और पढ़ें


Singapore Clinical Trial: A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Retained Gastric Contents Using Gastric Ultrasound in Participants with Type 2 Diabetes Mellitus and Participants with Overweight or Obesity without Type 2 Diabetes Mellitus.

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'A Study to Evaluate the Effect of Fasting Duration and Temporary Withholding of Tirzepatide on Re... और पढ़ें


Singapore Clinical Trial: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination With Pembrolizumab (MK-3475) With or Without Chemotherapy in Participants With 1L Locally Advanced Unresectable/Metastatic Esophageal Cancer: KEYMAKER-U06 Substudy 06E

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents in Combination W... और पढ़ें


Singapore Clinical Trial: EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease

Singapore, March 30 -- The Health Sciences Authority received information related to the study titled 'EASi-PROTKT™ - A Phase III double-blind, randomised, parallel-group superiority trial to evaluate... और पढ़ें


Singapore Company Announcement: VINPEARL JOINT STOCK COMPANY

Singapore, March 30 -- VINPEARL JOINT STOCK COMPANY made the following announcement: Security Name: VINPEARL US$150M9.5%B290820 General Announcement::Exchange and Cancellation of a portion of outsta... और पढ़ें


Singapore Company Announcement: GP INDUSTRIES LIMITED

Singapore, March 30 -- GP INDUSTRIES LIMITED made the following announcement: Security Name: GP INDUSTRIES LIMITED Change - Announcement of Appointment::Appointment Of Deputy Chief Executive Officer... और पढ़ें


Singapore Company Announcement: OVERSEA-CHINESE BANKING CORPORATION LIMITED

Singapore, March 30 -- OVERSEA-CHINESE BANKING CORPORATION LIMITED made the following announcement: Security Name: OVERSEA-CHINESE BANKING CORP Employee Stock Option/ Share Scheme::Notice of Use of ... और पढ़ें


Singapore Company Announcement: SINGAPORE EXCHANGE SECURITIES TRADING LIMITED

Singapore, March 30 -- SINGAPORE EXCHANGE SECURITIES TRADING LIMITED made the following announcement: Security Name: NA Buying-In::BUYING-IN EXECUTED ON MARCH 27, 2026 (https://links.sgx.com/1.0.0/c... और पढ़ें


Singapore Company Announcement: SINGAPORE TELECOMMUNICATIONS LIMITED

Singapore, March 30 -- SINGAPORE TELECOMMUNICATIONS LIMITED made the following announcement: Security Name: SINGTEL Share Buy Back - Daily Share Buy-Back Notice::S$2Bn Value Realisation Share Buy-ba... और पढ़ें


Singapore Company Announcement: GP INDUSTRIES LIMITED

Singapore, March 30 -- GP INDUSTRIES LIMITED made the following announcement: Security Name: GP INDUSTRIES LIMITED Change - Announcement of Appointment::Appointment Of Chief Executive Officer (https... और पढ़ें